These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 18821677)

  • 1. An intriguing relationship between the immune response to citrullinated vimentin and the HLA shared epitope: comment on the article by Verpoort et al.
    Bell DA; Hill JA; Cairns E
    Arthritis Rheum; 2008 Oct; 58(10):3277; author reply 3277-8. PubMed ID: 18821677
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of citrullinated vimentin peptides as T cell epitopes in HLA-DR4-positive patients with rheumatoid arthritis.
    Feitsma AL; van der Voort EI; Franken KL; el Bannoudi H; Elferink BG; Drijfhout JW; Huizinga TW; de Vries RR; Toes RE; Ioan-Facsinay A
    Arthritis Rheum; 2010 Jan; 62(1):117-25. PubMed ID: 20039411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The molecular basis underlying T cell specificity towards citrullinated epitopes presented by HLA-DR4.
    Loh TJ; Lim JJ; Jones CM; Dao HT; Tran MT; Baker DG; La Gruta NL; Reid HH; Rossjohn J
    Nat Commun; 2024 Jul; 15(1):6201. PubMed ID: 39043656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of chimeric vimentin citrullinated peptides for the diagnosis of rheumatoid arthritis.
    Malakoutikhah M; Gómara MJ; Gómez-Puerta JA; Sanmartí R; Haro I
    J Med Chem; 2011 Nov; 54(21):7486-92. PubMed ID: 21981664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking and HLA-DR shared epitope alleles in rheumatoid arthritis: comment on the article by Padyukov et al.
    Mattey DL; Hutchinson D
    Arthritis Rheum; 2005 Nov; 52(11):3675-6; author reply 3676-8. PubMed ID: 16258906
    [No Abstract]   [Full Text] [Related]  

  • 6. Is expression of intracellular citrullinated proteins in synovial tissue specific for rheumatoid arthritis? Comment on the article by Baeten et al.
    Smeets TJ; Vossenaar ER; van Venrooij WJ; Tak PP
    Arthritis Rheum; 2002 Oct; 46(10):2824-6; author reply 2826-7. PubMed ID: 12384951
    [No Abstract]   [Full Text] [Related]  

  • 7. Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.
    van der Linden MP; van der Woude D; Ioan-Facsinay A; Levarht EW; Stoeken-Rijsbergen G; Huizinga TW; Toes RE; van der Helm-van Mil AH
    Arthritis Rheum; 2009 Aug; 60(8):2232-41. PubMed ID: 19644872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Citrullinated antigens: just diagnostic tools or pathogenic targets in rheumatoid arthritis?
    Feist E; Burmester GR
    J Rheumatol; 2006 Nov; 33(11):2103-4. PubMed ID: 17086596
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis.
    Lac P; Saunders S; Tutunea-Fatan E; Barra L; Bell DA; Cairns E
    J Autoimmun; 2018 May; 89():75-81. PubMed ID: 29242008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.
    Carrier N; Cossette P; Daniel C; de Brum-Fernandes A; Liang P; Ménard HA; Boire G
    Arthritis Rheum; 2009 Mar; 60(3):698-707. PubMed ID: 19248090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
    Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L
    Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shared epitope and anti-cyclic citrullinated peptide antibodies: relationship with age at onset and duration of disease in rheumatoid arthritis.
    Varadé J; Loza-Santamaría E; Fernández-Arquero M; Lamas JR; de Los Angeles Figueredo M; Jover JA; de la Concha EG; Rodríguez L; Urcelay E; Fernández-Gutiérrez B; Martínez-Doncel A
    J Rheumatol; 2009 May; 36(5):1085-6. PubMed ID: 19435975
    [No Abstract]   [Full Text] [Related]  

  • 13. T cell responses to citrullinated self-peptides in patients with rheumatoid arthritis.
    Aggarwal A; Srivastava R; Agrawal S
    Rheumatol Int; 2013 Sep; 33(9):2359-63. PubMed ID: 23543349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of citrulline-specific autoantibodies in animal models of autoimmunity.
    Vossenaar ER; van Boekel MA; van Venrooij WJ; López-Hoyoz M; Merino J; Merino R; Joosten LA
    Arthritis Rheum; 2004 Jul; 50(7):2370-2. PubMed ID: 15248238
    [No Abstract]   [Full Text] [Related]  

  • 15. Somatic mutations and anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis: comment on the editorial by Levesque et al.
    Firestein GS
    Arthritis Rheum; 2010 Jan; 62(1):303-4. PubMed ID: 20039399
    [No Abstract]   [Full Text] [Related]  

  • 16. Pathogenic relevance of anti-citrullinated vimentin antibodies: comment on the article by Montes et al.
    van der Woude D; Scherer HU; Huizinga TW; Toes RE
    Arthritis Rheum; 2013 Feb; 65(2):541-2. PubMed ID: 23055177
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply: Pathogenic relevance of anti-citrullinated vimentin antibodies: comment on the article by Montes et al.
    Montes A; Perez-Pampin E; Calaza M; Gomez-Reino JJ; Gonzalez A
    Arthritis Rheum; 2013 Feb; 65(2):542. PubMed ID: 23055154
    [No Abstract]   [Full Text] [Related]  

  • 18. Arthritis induced by posttranslationally modified (citrullinated) fibrinogen in DR4-IE transgenic mice.
    Hill JA; Bell DA; Brintnell W; Yue D; Wehrli B; Jevnikar AM; Lee DM; Hueber W; Robinson WH; Cairns E
    J Exp Med; 2008 Apr; 205(4):967-79. PubMed ID: 18391064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies against mutated citrullinated vimentin and cyclic citrullinated peptide in children with juvenile idiopathic arthritis.
    Morbach H; Dannecker H; Kerkau T; Girschick HJ
    Clin Exp Rheumatol; 2010; 28(5):800. PubMed ID: 20822716
    [No Abstract]   [Full Text] [Related]  

  • 20. Citrullinated proteins in rheumatoid arthritis: crucial...but not sufficient!
    Cantaert T; De Rycke L; Bongartz T; Matteson EL; Tak PP; Nicholas AP; Baeten D
    Arthritis Rheum; 2006 Nov; 54(11):3381-9. PubMed ID: 17075816
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.